Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RM-131 Single Dose in Chronic Constipation
NCT02137642Phase 1Completed
- Sponsor
- Motus Therapeutics, Inc.
- Start
- Aug 2014
- Primary completion
- Nov 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chronic idiopathic constipation (CIC) comparing RM-131 with Placebo (2 arms). Primary endpoint: Effect of RM-131 on postprandial high amplitude propagated contractions (HAPC) per hour at 2 hours. Started Aug 2014; status: completed.
02
Drugs
relamorelin
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT02137642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137642.